These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11835952)

  • 1. The safety of triptans in the treatment of patients with migraine.
    Jamieson DG
    Am J Med; 2002 Feb; 112(2):135-40. PubMed ID: 11835952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and rational use of the triptans.
    Tepper SJ
    Med Clin North Am; 2001 Jul; 85(4):959-70. PubMed ID: 11480267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is selective 5-HT
    Rubio-Beltrán E; Labastida-Ramírez A; Villalón CM; MaassenVanDenBrink A
    Pharmacol Ther; 2018 Jun; 186():88-97. PubMed ID: 29352859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triptans.
    Armstrong SC; Cozza KL
    Psychosomatics; 2002; 43(6):502-4. PubMed ID: 12444236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the safety and tolerability profile of acute treatments for migraine.
    Martin VT; Goldstein JA
    Am J Med; 2005 Mar; 118 Suppl 1():36S-44S. PubMed ID: 15841886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Triptans in migraine--here and now (15 years after they were implemented in therapy)].
    Prusiński A; Rozniecki JJ
    Neurol Neurochir Pol; 2005; 39(4 Suppl 1):S68-77. PubMed ID: 16419574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety profile of the triptans.
    Tepper SJ; Millson D
    Expert Opin Drug Saf; 2003 Mar; 2(2):123-32. PubMed ID: 12904112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the 5-HT
    Huang PC; Yang FC; Chang CM; Yang CP
    Prog Brain Res; 2020; 255():99-121. PubMed ID: 33008517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of action of the 5-HT1B/1D receptor agonists.
    Tepper SJ; Rapoport AM; Sheftell FD
    Arch Neurol; 2002 Jul; 59(7):1084-8. PubMed ID: 12117355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting to 5-HT1F receptor subtype for migraine treatment: lessons from the past, implications for the future.
    Mitsikostas DD; Tfelt-Hansen P
    Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):241-9. PubMed ID: 22934751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin receptor ligands: treatments of acute migraine and cluster headache.
    Goadsby PJ
    Handb Exp Pharmacol; 2007; (177):129-43. PubMed ID: 17087122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of 5-hydroxytryptamine1B/1D/1F receptors as a mechanism of action of antimigraine drugs.
    Ramírez Rosas MB; Labruijere S; Villalón CM; Maassen Vandenbrink A
    Expert Opin Pharmacother; 2013 Aug; 14(12):1599-610. PubMed ID: 23815106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5HT1F- and 5HT7-receptor agonists for the treatment of migraines.
    Agosti RM
    CNS Neurol Disord Drug Targets; 2007 Aug; 6(4):235-7. PubMed ID: 17691977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Almotriptan: an effective and well-tolerated treatment for migraine pain.
    Pascual J
    Drugs Today (Barc); 2003; 39 Suppl D():31-6. PubMed ID: 15071618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
    Deleu D; Hanssens Y
    Acta Neurol Belg; 1999 Jun; 99(2):85-95. PubMed ID: 10427351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient treatment preferences and the 5-HT1B/1D agonists.
    Ryan RE
    Arch Intern Med; 2001 Nov; 161(21):2545-53. PubMed ID: 11718585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of 5-HT(1B), 5-HT(1D) and 5-HT(1F) receptor expression in rat trigeminal and dorsal root ganglia neurons: relevance to the selective anti-migraine effect of triptans.
    Classey JD; Bartsch T; Goadsby PJ
    Brain Res; 2010 Nov; 1361():76-85. PubMed ID: 20833155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: a migraine target?
    Shields KG; Goadsby PJ
    Neurobiol Dis; 2006 Sep; 23(3):491-501. PubMed ID: 16875831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine.
    Dodick D; Lipton RB; Martin V; Papademetriou V; Rosamond W; MaassenVanDenBrink A; Loutfi H; Welch KM; Goadsby PJ; Hahn S; Hutchinson S; Matchar D; Silberstein S; Smith TR; Purdy RA; Saiers J;
    Headache; 2004 May; 44(5):414-25. PubMed ID: 15147249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naratriptan.
    Massiou H
    Curr Med Res Opin; 2001; 17 Suppl 1():s51-3. PubMed ID: 12463278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.